What fixed-dose combination cream of calcipotriene (0.005%) and betamethasone dipropionate (0.064%) is recommended for treating active plaque psoriasis, and how should it be applied?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fixed-Dose Combination Cream for Plaque Psoriasis

The fixed-dose combination of calcipotriene 0.005% and betamethasone dipropionate 0.064% is strongly recommended for treating active plaque psoriasis, applied once or twice daily as a thin layer rubbed in gently and completely. 1, 2

Recommended Formulations and Application

The combination product is available in multiple formulations (cream, ointment, gel, foam), with the specific formulation choice depending on the treatment site:

  • Body/trunk psoriasis: Apply cream or ointment once or twice daily 1, 2
  • Scalp psoriasis: Use gel or foam formulation for 4-12 weeks 1
  • Facial psoriasis: Consider calcipotriene combined with hydrocortisone (lower potency steroid) for 8 weeks 1

Evidence Supporting This Recommendation

The 2021 Joint AAD-NPF Guidelines provide Grade A evidence (strongest recommendation) for combination calcipotriene/betamethasone products 1. The landmark 52-week study demonstrated that 69-74% of patients achieved clear or almost clear skin compared to only 27% with vehicle control (P < .001) 1. Critically, no serious adverse events occurred, including no striae formation or hypothalamic-pituitary-adrenal axis suppression over the entire 52-week period 1.

Treatment Duration and Protocols

The combination can be used safely for up to 52 weeks, which is exceptional for a topical corticosteroid-containing product 1. This extended safety profile makes it suitable for:

  • Acute treatment: Once or twice daily until clear/almost clear
  • Long-term maintenance: Can continue up to 52 weeks
  • Adjunctive therapy: Combine with systemic/biologic treatments for residual lesions 3, 4

Alternative dosing schedules for maintenance include:

  • Vitamin D analogue twice daily on weekdays + high-potency corticosteroid twice daily on weekends 1
  • Morning corticosteroid + evening vitamin D analogue 1

Critical Clinical Considerations

Avoid simultaneous use with salicylic acid - the acidic pH inactivates calcipotriene and reduces effectiveness 1

Phototherapy timing: If combining with phototherapy, apply the cream AFTER the UV treatment to prevent:

  • UVA-induced degradation of calcipotriene
  • Thick cream layers blocking UVB penetration 1

Why This Combination Works

The combination is more effective than either agent alone 1. While ultrapotent/potent corticosteroids alone outperform calcipotriene monotherapy at 3-8 weeks, the combination of calcipotriene with betamethasone dipropionate demonstrates superior efficacy compared to betamethasone monotherapy 1. The vitamin D analogue (calcipotriene) inhibits keratinocyte proliferation and enhances differentiation, while the corticosteroid provides anti-inflammatory effects 1.

Practical Advantages

The cream formulation using PAD (polyaphron dispersion) technology offers improved cosmetic characteristics that enhance patient adherence - a critical factor for treatment success 3, 4. Real-world evidence confirms effectiveness in difficult-to-treat areas including scalp, pretibial regions, and palmoplantar surfaces 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.